CHAPTER 1

Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–1712.

Arslan RC, Schilling KM, Gerlach TM, Penke L. Salivary immunoassays of estradiol have subpar validity for evaluating reproductive and menopausal steroids. Psychoneuroendocrinology. 2023;152:106096.

Bancroft J, Cawood EH. Androgen levels and sexual interest in women: The role of SHBG and free testosterone. Psychoneuroendocrinology. 1996;21(7):587–598.

Brouillard A, et al. Comparison of immunoassay and liquid chromatography–tandem mass spectrometry for measurement of estradiol, progesterone, and testosterone in saliva. Psychoneuroendocrinology. 2025.

Donovitz GS, et al. Society position statements on bioidentical hormones, misinformation, and patient safety. Proceedings (Bayl Univ Med Cent). 2021;34(4):517–520.

Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: Binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. Journal of Clinical Endocrinology & Metabolism. 1981;53(1):58–68.

Goodman NF, Cobin RH, Ginzburg SB, Katz IA, Woode DE; AACE Reproductive Endocrinology Scientific Committee. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocrine Practice. 2011;17(Suppl 6):1–25.

Gregory S, et al. Establishing reference ranges for salivary steroid hormones using LC-MS/MS in adults. Clinical Chemistry and Laboratory Medicine. 2023.

Gruenstein EI, et al. Validation of a dried blood spot assay for testosterone measurement using liquid chromatography–tandem mass spectrometry. Clinical Biochemistry. 2024.

Hammond GL. Access of reproductive steroids to target tissues. Obstetrics and Gynecology Clinics of North America. 2002;29(3):411–423.

Harper-Harrison G, et al. Hormone replacement therapy. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2024.

Huang T, et al. Correlation between salivary and serum gonadal hormone concentrations: Methodological considerations and clinical implications. American Journal of Physiology – Endocrinology and Metabolism. 2023.

Järvinen AJ, et al. Absorption and bioavailability of oestradiol from gel, patch, and tablet formulations in postmenopausal women. Maturitas. 1999;32(2):103–113.

Kuhl H. Pharmacology of estrogens and progestogens: Influence of different routes of administration. Climacteric. 2005;8(Suppl 1):3–63.

National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington, DC: National Academies Press; 2020.

Newman MS, et al. Reliability of a dried urine test for comprehensive assessment of steroid hormones and metabolites. BMC Chemistry. 2021;15:19.

O’Leary P, Flett P, Beilby J, Phillips PJ. Pharmacokinetics of sublingual estrogen therapy in postmenopausal women. Menopause. 2000;7(2):138–142.

Reginster JY, et al. Estradiol pharmacokinetics after transdermal application: Matrix versus reservoir patches. Climacteric. 2000.

Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Position statement: Utility, limitations, and pitfalls in measuring testosterone. Journal of Clinical Endocrinology & Metabolism. 2007;92(2):405–413.

Sakkas D, et al. Multi-centre evaluation of salivary hormone testing compared with serum for estradiol and progesterone. Reproductive Biomedicine Online. 2021.

Slettvoll T, et al. Non-invasive assessment of free steroid hormones: LC-MS/MS method development for saliva testing. Analytical and Bioanalytical Chemistry. 2025.

The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022.

Utian WH. The International Menopause Society menopause-related terminology definitions. Climacteric. 1999;2(4):284–286.

Waddell BJ, O’Leary P. Tissue concentrations of estradiol following topical application: Implications for hormone replacement therapy. Clinical Endocrinology (Oxf). 2002;57(5):613–618.

Wilson JD. The metabolism of progesterone in man. Recent Progress in Hormone Research. 1996;51:23–50.

Wilson JF. Menopause and the aging female reproductive system. In: Gardner DG, Shoback D, eds. Greenspan’s Basic & Clinical Endocrinology. 9th ed. New York, NY: McGraw-Hill Education; 2011.

Zava DT, Blen M, Duwe G. Salivary progesterone and estradiol measurement: Validation and clinical application. Clinical Chemistry. 1993;39(11):2252–2258.

Zava DT, Dollbaum CM, Blen M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proceedings of the Society for Experimental Biology and Medicine. 1998;217(3):369–378.

Zava DT, Dollbaum CM, Thakar VV. Validation of dried urine hormone testing for monitoring hormone replacement therapy. Alternative Medicine Review. 2004;9(3):234–241.

Zava DT, Huggins GR. Estrogen and progesterone metabolites: Relationship to breast cancer risk factors. Steroids. 1998;63(5–6):287–291.

Zava DT, Zava CA. Estrogen metabolism and breast cancer risk: A review of the evidence. Journal of Nutrition. 2007;137(2 Suppl):S219–S226.

Zava DT, Zava CA. Dried urine testing for steroid hormones and metabolites: Clinical applications and interpretation. Integrative Medicine (Encinitas). 2013;12(1):18–25.

 

CHAPTER 2 

Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29(1):76-131.

Brent GA. Mechanisms of thyroid hormone action. J Clin Invest. 2012;122(9):3035-3043.

El-Farhan N, Rees DA, Evans C. Measuring cortisol in serum, urine and saliva: are our assays good enough? Ann Clin Biochem. 2017;54(3):308-322.

Fliers E, Bianco AC, Langouche L, Boelen A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 2015;3(10):816-825.

Gibson S, Checkley S, Papadopoulos A, Poon L, Daley S, Wardle J. Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med. 1999;61(2):214-224.

Hansen AM, Garde AH, Christensen JM, Eller NH, Netterstrøm B. Reference intervals and variation for urinary cortisol and cortisone in healthy subjects. Clin Chem Lab Med. 2003;41(4):552-560.

Hennessey JV. The emergence of levothyroxine as a treatment for hypothyroidism. Endocrine. 2017;55(1):6-18.

Hoermann R, Midgley JEM, Larisch R, Dietrich JW. Relational stability of thyroid hormones in euthyroid subjects and patients with autoimmune thyroid disease. Eur Thyroid J. 2016;5(3):171-179.

Kempke S, Luyten P, Van Wambeke P, et al. Salivary cortisol response to awakening in chronic fatigue syndrome. Psychosom Med. 2013;75(6):561-569.

Midgley JEM, Larisch R, Dietrich JW, Hoermann R. Variation in the biochemical response to L-thyroxine therapy and relationship with peripheral thyroid hormone conversion efficiency. Endocr Connect. 2015;4(3):R13-R25.

Nicoloff JT, Lopresti JS. Nonthyroidal illness syndrome. Annu Rev Med. 1993;44:141-152.

Papanicolaou DA, Yanovski JA, Cutler GB Jr, Chrousos GP. A single midnight serum cortisol measurement distinguishes Cushing’s syndrome from pseudo-Cushing states. J Clin Endocrinol Metab. 1998;83(4):1163-1167.

Persani L. Clinical review: central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab. 2012;97(9):3068-3078.

Russell GM, Kalafatakis K, Lightman SL. The importance of biological rhythms in stress hormone measurement. Clin Endocrinol (Oxf). 2015;82(5):619-628.
Saravanan P, Chau WF, Roberts N, Vedhara K, Greenwood R, Dayan CM. Psychological well-being in patients on “adequate” doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrinol (Oxf). 2002;57(5):577-585.

Spencer CA, Schwarzbein D, Guttler RB, LoPresti JS, Wheeler MH. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer. Thyroid. 1998;8(9):737-744.

Stalder T, Kirschbaum C. Analysis of cortisol in hair—state of the art and future directions. Brain Behav Immun. 2012;26(7):1019-1029.

Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of thyroid function tests. Clin Chem Lab Med. 2003;41(7):862-874.

Vining RF, McGinley RA, Maksvytis JJ, Ho KY. Salivary cortisol: a better measure of adrenal cortical function than serum cortisol. Ann Clin Biochem. 1983;20(Pt 6):329-335.

Wardle J, Steptoe A, Gibson EL, et al. Stress and cortisol response to a low-fat meal. Psychosom Med. 2000;62(6):828-836.

Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005;90(9):5483-5488.

Zava DT, Zava I. Validation of dried urine hormone testing for the assessment of cortisol and cortisol metabolites. J Steroid Biochem Mol Biol. 2020;198:105554.

Zava DT, Zava I, Park YJ. Salivary hormone testing: validation of a noninvasive method for assessing cortisol and steroid hormone exposure. Altern Ther Health Med. 2005;11(2):24-34.

 

CHAPTER 3

Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability—a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.

Bouatra S, Aziat F, Mandal R, et al. The human urine metabolome. PLoS One. 2013;8(9):e73076.

Brandtzaeg P. Secretory IgA: designed for anti-microbial defense. Front Immunol. 2013;4:222.

Camilleri M, Lasch K, Zhou W. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Am J Physiol Gastrointest Liver Physiol. 2012;303(7):G775–G785.

Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761–1772.

Domínguez-Muñoz JE. Pancreatic enzyme therapy for pancreatic exocrine insufficiency. Curr Gastroenterol Rep. 2007;9(2):116–122.

Domínguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin Gastroenterol. 2018;34(5):349–354.

Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann N Y Acad Sci. 2012;1258:25–33.

Fernandez-Banares F, Esteve M, Salas A, et al. Systematic evaluation of the causes of chronic watery diarrhea. Am J Gastroenterol. 2007;102(11):2520–2528.

Fine KD, Ogunji F, Saloum Y, Beharry S, Crippin J. The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology. 1997;112(6):1830–1838.

Ghosh SS, Wang J, Yannie PJ, Ghosh S. Intestinal barrier dysfunction, LPS translocation, and disease. Aging Dis. 2020;11(3):517–532.

Holtmann G, Talley NJ. Functional dyspepsia. Curr Opin Gastroenterol. 2015;31(6):492–498.

Keller J, Layer P. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005;54(suppl 6):vi1–vi28.

Layer P, Keller J. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol. 1999;28(1):3–10.

Leech B, Schloss PD. Short-chain fatty acids as modulators of the gut microbiome. Trends Microbiol. 2021;29(9):824–835.

Lembcke B. Diagnosis of fat malabsorption. Best Pract Res Clin Gastroenterol. 2010;24(3):277–285.

Loser C, Mollgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996;39(4):580–586.

Macpherson AJ, Slack E, Geuking MB, McCoy KD. The mucosal firewalls against commensal intestinal microbes. Semin Immunopathol. 2009;31(2):145–149.

Odenwald MA, Turner JR. The intestinal epithelial barrier: a therapeutic target? Nat Rev Gastroenterol Hepatol. 2017;14(1):9–21.
Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018;72(2):e13066.

Pérez-Burillo S, Pastoriza S, Gironés R, et al. Relationship between gut microbiota composition and intestinal permeability. Nutrients. 2021;13(9):2972.
Quigley EMM. Gut bacteria in health and disease. Gastroenterol Hepatol (N Y). 2013;9(9):560–569.

Serrano-Pertierra E, Oliveira A, Roca M, et al. Biomarkers for intestinal malabsorption and nutrient uptake. Nutrients. 2020;12(6):1738.

Shulman RJ, Eakin MN, Czyzewski DI, Jarrett M, Ou CN. Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome. J Pediatr. 2008;153(5):646–650.

Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol. 2020;20(1):40–54.

Vancamelbeke M, Vermeire S. The intestinal barrier: a fundamental role in health and disease. Expert Rev Gastroenterol Hepatol. 2017;11(9):821–834.

Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(1):35–56.

​

​

CHAPTER 4

Carr S, Chan E, Lavine E, Moote W. CSACI position statement on the testing of food-specific IgG. Allergy Asthma Clin Immunol. 2012;8(1):12.

Cui L, Morris A, Ghedin E. The human mycobiome in health and disease. Genome Med. 2013;5(7):63.

Hall GS, Pratt-Rippin K, Meisler DM, Washington JA. Clinical significance of Candida antibodies. Diagn Microbiol Infect Dis. 1987;7(1):1–7.

Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185–1196.

Maes M, Mihaylova I, Leunis JC. Increased IgA and IgM responses to food antigens in metabolic and inflammatory disorders. Mol Neurobiol. 2007;36(1):1–8.

Matsumoto K, Inoue H. Food allergy and intolerance in relation to obesity. Allergol Int. 2014;63(2):163–170.

Odds FC. Candida and candidosis: a review and bibliography. Baillieres Clin Obstet Gynaecol. 1988;2(1):115–130.

Quigley EMM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130(2 suppl 1):S78–S90.

Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112(5):775–784.

Saad RJ, Chey WD. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Clin Gastroenterol Hepatol. 2014;12(12):1964–1972.

Schink M, Konturek PC, Tietz E, et al. Microbial patterns in patients with histamine intolerance. J Physiol Pharmacol. 2018;69(4):579–593.

Stapleton M, Howard-Thompson A, George C, Hoover RM, Self TH. Food allergy and food intolerance: a review of the literature. J Am Osteopath Assoc. 2012;112(10):716–724.

Strati F, Di Paola M, Stefanini I, et al. Age and gender affect the composition of fungal populations of the human gastrointestinal tract. Front Microbiol. 2016;7:1227.

Wang X, Li X, Xu H, et al. Association between food-specific IgG antibodies and body mass index, insulin resistance, and inflammatory markers. Clin Nutr. 2020;39(8):2504–2511.

Wilders-Truschnig M, Mangge H, Lieners C, Gruber HJ, Mayer C, März W. IgG antibodies against food antigens are correlated with inflammation and metabolic markers in overweight and obese adults. Int Arch Allergy Immunol. 2008;147(1):34–41.

Wilders-Truschnig M, Mangge H, Lieners C, et al. Food-specific IgG antibodies are associated with chronic low-grade inflammation in obesity. Obesity (Silver Spring). 2009;17(10):1933–1939.

Zuo HJ, Xue B, Hu ZL, et al. Serum food-specific IgG antibodies are associated with metabolic syndrome in Chinese adults. Nutrients. 2018;10(6):810.

 

CHAPTER 5

Allen LH. Causes of vitamin B12 and folate deficiency. Food Nutr Bull. 2008;29(2 Suppl):S20-S34.

Apostoli P. Biomonitoring of metals: strengths, weaknesses, and interpretation issues. J Toxicol Environ Health A. 2002;65(20):1459-1470.

ATSDR. Toxicological profile for lead. Agency for Toxic Substances and Disease Registry. Updated 2023.

Aylward LL, Hays SM. Biomonitoring equivalents for interpreting human biomonitoring data for metals. Regul Toxicol Pharmacol. 2008;51(3):S49-S63.

Bailey RL, West KP Jr, Black RE. The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 2015;66(Suppl 2):22-33.

Bailey RL, et al. Serum versus red blood cell folate concentrations and their association with metabolic outcomes. Clin Chem. 2017;63(6):1044-1052.

Bock KW. The UDP-glycosyltransferase (UGT) superfamily: coordinated regulation and pharmacological impact. Drug Metab Rev. 2016;48(3):281-299.

Chen Z, Zheng L, Jiang J, et al. The role of phase I and phase II drug-metabolizing enzymes in xenobiotic detoxification and metabolic health. Front Pharmacol. 2022;13:887633.

Cooper GM, et al. Urinary organic acids as functional markers of nutrient status. Clin Biochem. 2016;49(12):899-908.

Cosnes J, et al. Nutritional consequences of inflammatory bowel disease. Gastroenterology. 2011;140(6):1673-1681.

de Baaij JHF, Hoenderop JGJ, Bindels RJM. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1-46.

Frederiksen H, Skakkebaek NE, Andersson AM. Metabolism of phthalates in humans. Mol Nutr Food Res. 2007;51(7):899-911.

Fuhrman BJ, Schairer C, Gail MH, et al. Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 2012;104(4):326-339.

Genuis SJ, Sears ME. Assessing toxic exposures in clinical practice: interpretation of blood, urine, hair, and nail testing. Altern Med Rev. 2010;15(1):14-22.

Gropper SS, Smith JL, Carr TP. Advanced nutrition and human metabolism. 7th ed. Cengage Learning; 2018.

Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.

Huang J, Hu H, Wu Y, et al. Hair and nail analysis for biomonitoring of heavy metals: advantages and limitations. Biol Trace Elem Res. 2020;196(1):1-8.

Jia W, Xie G, Jia W. Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111-128.

King JC. Zinc: an essential but elusive nutrient. Am J Clin Nutr. 2011;94(2):679S-684S.

Klaassen CD, Watkins JB. Mechanisms of bile formation, hepatic uptake, and biliary excretion. Pharmacol Rev. 1984;36(1):1-67.

Klee GG. Dried blood spot testing: applications and limitations. Clin Chem. 2014;60(5):713-714.

Koch HM, Calafat AM. Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci. 2009;364(1526):2063-2078.

Needham LL, Calafat AM, Barr DB. Uses and issues of biomonitoring. Int J Hyg Environ Health. 2007;210(3-4):229-238.

Panda C, Komarnytsky S, Fleming MN, et al. Guided metabolic detoxification supports Phase II detoxification enzymes and antioxidant balance in healthy adults. Nutrients. 2023;15(9):2209.

Sears ME, Kerr KJ, Bray RI. Arsenic, cadmium, lead, and mercury in hair, nails, blood, and urine: a systematic review. J Environ Public Health. 2012;2012:184745.

Silva MJ, Barr DB, Reidy JA, et al. Urinary levels of seven phthalate metabolites in the U.S. population. Environ Health Perspect. 2004;112(3):331-338.

Smith DR, Flegal AR. Lead in the biosphere: recent trends. Ambio. 1995;24(1):21-23.

Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149-160.

Sui Y, Wu J, Chen J. The role of β-glucuronidase in gut microbiota-mediated estrogen metabolism and enterohepatic circulation. Front Endocrinol (Lausanne). 2021;12:631730.

Tate JR, Johnson R, Cox J, et al. Limitations of serum ferritin in the diagnosis of iron deficiency. Clin Biochem Rev. 2017;38(3):147-158.

Teeguarden JG, Twaddle NC, Churchwell MI, et al. Urinary and serum bisphenol A pharmacokinetics in humans following ingestion. Toxicol Appl Pharmacol. 2011;255(2):128-136.

Volpe SL. Magnesium in disease prevention and overall health. Adv Nutr. 2013;4(3):378S-383S.

Walsh J, Griffin BT, Clarke G, Hyland NP. Drug-gut microbiota interactions: implications for metabolism and toxicity. Mol Pharm. 2018;15(8):2926-2941.

Ye X, Wong LY, Bishop AM, Calafat AM. Variability of urinary concentrations of bisphenol A in spot samples, first-morning voids, and 24-hour collections. Environ Health Perspect. 2011;119(7):983-988.

Ziegler RG, Fuhrman BJ, Moore SC, Matthews CE. Epidemiologic studies of estrogen metabolism and breast cancer. Steroids. 2015;99(Pt A):67-75.

 

CHAPTER 6

American College of Obstetricians and Gynecologists’ Committee on Clinical Consensus–Gynecology. Compounded bioidentical menopausal hormone therapy: ACOG Clinical Consensus No. 6. Obstet Gynecol. 2023;142(5):1266–1273.

Archer DF. Testosterone supplementation: oral, transdermal, and pellet therapy. Rev Urol. 2006;8(Suppl 3):S48–S53.

Boardman HMP, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database of Systematic Reviews. 2023;3:CD002229.

Castelo-Branco C, Gambacciani M, Cano A, Minkin MJ, Rachoń D. Review and meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence. Climacteric. 2021;24(2):115-123.

Chadwick KA, Simpson CB, McGarey PO Jr, Estes CM, Nix J, Sulica L. Voice Change Following Testosterone Supplementation in Women: A Multi-Institutional Case Series. J Voice. 2021;35(6):936.e1-936.e7.

Chlebowski RT, Anderson GL, Sarto GE, et al. Colorectal cancer incidence and mortality in postmenopausal women after stopping estrogen plus progestin therapy. Journal of the National Cancer Institute. 2010;102(22):1725–1735.

Collaborative Group on Hormonal Factors in Breast Cancer. Menopausal hormone therapy and breast cancer risk: Individual participant meta-analysis of worldwide epidemiological evidence. The Lancet. 2019;394(10204):1159–1168.

Csupor D, Lantos T, Hegyi P, Benko R, Viola R. Vitex agnus-castus in premenstrual syndrome: a meta-analysis of double-blind randomized controlled trials. Complementary Therapies in Medicine. 2019;47:102190.

Donovitz GS. Bioidentical hormone pellet therapy: an individualized approach to hormone therapy in women. Ther Adv Endocrinol Metab. 2020;11:2042018820930403.

Gambacciani M, Levancini M. Hormone replacement therapy and the prevention of postmenopausal metabolic syndrome. Climacteric. 2021;24(4):365-371.
Gersh F, O'Keefe JH, Elagizi A, Lavie CJ, Laukkanen JA. Estrogen and cardiovascular disease. Prog Cardiovasc Dis. 2024;84:60-67.

Glaser RL, York AE. Subcutaneous testosterone pellet therapy in women: pharmacokinetics, safety, and outcomes. Therapeutic Advances in Endocrinology and Metabolism. 2021;12:20420188211015474.

Gomez F, de la Cueva R, Escobar-Jimenez F, et al. Subcutaneous hormone pellet therapy in postmenopausal women: pharmacokinetics and clinical response. Maturitas. 2007;56(4):410–418.

Harman SM, Brinton EA, Cedars M, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 2005;8(1):3-12.

Hedaoo K, Shukla S, Jagtap S, et al. Exploring the efficacy and safety of black cohosh (Cimicifuga racemosa) in treating menopausal symptoms: a review and clinical perspective. Journal of Menopausal Medicine. 2024;15010:1-9.

Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D. Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis. Neurology. 2016;87(7):699-708.

Hodis HN, Mack WJ. A “window of opportunity:” The reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent. Brain Res. 2011;1379:244-252.

Hodis HN, Mack WJ. Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It Is About Time and Timing. Cancer J. 2022;28(3):208-223.

Holtorf K. The bioidentical hormone debate: are bioidentical hormones (estradiol, estriol, and progesterone) safer or more efficacious than commonly used synthetic versions in hormone replacement therapy? Postgrad Med. 2009;121(1):73-85.

Hunter MS, Hardy C, Northover H. The impact of menopausal symptoms on work performance: a systematic review. Menopause. 2021;28(8):931-941.

Islam RM, Bell RJ, Green S, et al. Safety and efficacy of testosterone for women: a systematic review and meta-analysis. Lancet Diabetes & Endocrinology. 2019;7(10):754–766.

Kingsberg SA, Schaffir J, Goldstein I, et al. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE survey. Journal of Sexual Medicine. 2020;17(3):558-566.

Labrie F, Archer DF, Bouchard C, et al. Combined hormone replacement therapy with daily percutaneous estradiol and sublingual micronized progesterone. Menopause. 1999;6(4):273–279.

Lauby-Secretan B, Scoccianti C, Loomis D, et al. Breast cancer screening—viewpoint of the IARC Working Group. New England Journal of Medicine. 2015;372(24):2353–2358.

L’Hermite M. Bioidentical menopausal hormone therapy: registered hormones (estradiol, progesterone) preferable to compounded products. Climacteric. 2022;25(2):109–116.

L’Hermite M, Simoncini T, Fuller S, Genazzani AR. Could transdermal estradiol plus progesterone be a safer postmenopausal HRT? A review. Maturitas. 2008;60(3-4):185-201.

Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. BioMed Research International. 2020;2020:7574612.

Manson JE, Aragaki AK, Rossouw JE, et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: the Women’s Health Initiative randomized trials. JAMA. 2017;318(10):927-938.

Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women’s Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368.

Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and obesity. Endocrine Reviews. 2023;44(2):225-259.

Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Reviews. 2020;41(2):bnaa007.

Mong JA, Cusmano DM. Sex differences in sleep: impact of biological sex and sex steroids. Philosophical Transactions of the Royal Society B. 2023;378(1872):20210200.

Morselli LL, Mokhlesi B, Van Cauter E. Sex differences in sleep and sleep-disordered breathing. Journal of Clinical Endocrinology & Metabolism. 2020;105(6):e2198-e2213.

Naseri R, Akbari Z, Gholami M, et al. Comparison of Vitex agnus-castus extracts with placebo in alleviating menopausal symptoms: a randomized controlled study. Korean Journal of Family Medicine. 2019;40(3):165-172.

Newman M, Precision Analytic Group. 3,3′-diindolylmethane effects on the urinary estrogen profile in premenopausal women. BMC Complementary Medicine and Therapies. 2024;24:47.

Nunes E, Gallardo E, Morgado-Nunes S, Fonseca-Moutinho J. Steroid hormone levels in postmenopausal hysterectomised women with and without ovarian conservation: the continuous endocrine function of the ovaries. J Obstet Gynaecol. 2023;43(1):2141618.

O’Neill T, Reid R, Kay V. Impact of menopausal symptoms on women’s work performance, attendance, and career decisions. Occupational Medicine. 2023;73(6):332-339.

Pinkerton JV, Guico-Pabia CJ, Taylor HS. Menstrual cycle-related exacerbation of depressive symptoms in perimenopausal women and treatment considerations. Menopause. 2020;27(9):1037-1046.

Prior JC. Progesterone for symptomatic perimenopause treatment—a new option. Climacteric. 2019;22(3):319-326.

Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.

Safwan N. Menopause in the workplace: challenges, impacts, and economic implications. Maturitas. 2024;178:18-24.

Santoro N, Epperson CN, Mathews SB. Menopausal symptoms and their management. Endocrine Reviews. 2021;42(5):723–756.

Schweitzer K. New analysis of Women’s Health Initiative data aims to “clear the air” over menopausal hormone therapy. JAMA. 2025;334(15):1318-1320.

Shifren JL, Gass MLS. The North American Menopause Society recommendations for clinical care of midlife women. Menopause. 2023;30(5):573–590.

Simon JA, Kaunitz AM, Andrews MC, et al. Extended safety and efficacy of transdermal estradiol systems. Menopause. 2020;27(5):560–567.

Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2015;100(11):3975-4011.

Stute P, Wildt L, Neulen J. The impact of micronized progesterone on breast cancer risk: A systematic review. Climacteric. 2018;21(2):111–122.
The North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794.

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of breast cancer: Nested case-control studies using QResearch and CPRD databases. BMJ. 2020;371:m3873.

Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism. BMJ. 2019;364:k4810.

Zava DT, Zava D. Sublingual versus oral administration of hormone replacement therapy: clinical findings and patient outcomes. Int J Pharm Compd. 2004;8(4):314–318.

​

​

CHAPTER 7

Akturk HK, Chindris AM, Hines JM, Singh RJ, Bernet VJ. Over-the-counter “adrenal support” supplements contain thyroid and steroid-based adrenal hormones. Mayo Clin Proc. 2018;93(3):284-290.

Al Refaie A, Baldassini L, De Vita M, Gonnelli S, Caffarelli C. Vitamin D and adrenal gland: Myth or reality? A systematic review. Front Endocrinol (Lausanne). 2022;13:1001065.

Armanini D, Fiore C, Mattarello MJ, Bielenberg J, Palermo M. History of the endocrine effects of licorice. J Endocrinol Invest. 2020;43(10):1301-1308.
Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: An Endocrine Society clinical practice guideline update. J Clin Endocrinol Metab. 2020;105(8):dgaa376.

Boulle F, Sibley J, Kabongo M, et al. DHEA as a biomarker of stress: A systematic review and meta-analysis. Psychoneuroendocrinology. 2022;141:105740.

Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451-1462.

Carter B, Rees P, Hale L, Bhattacharjee D, Paradkar MS. Association between portable screen-based media device access or use and sleep outcomes: A systematic review and meta-analysis. JAMA Pediatr. 2016;170(12):1202-1208.

Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of light-emitting devices suppresses melatonin in humans. J Clin Endocrinol Metab. 2015;100(4):1703-1710.

Fleseriu M, Hashim IA, Karavitaki N, et al. Hormonal replacement in hypopituitarism and secondary adrenal insufficiency. Endocr Rev. 2021;42(6):758-789.

Heo JE, Lee H, Park S, Kim S. Impact of blue-light filtering on sleep and mood in shift workers. Chronobiol Int. 2022;39(6):843-854.

Hurt RT, Mundi MS, et al. Over-the-counter adrenal support supplements: Uncontrolled doses of cortisol and steroid hormones detected. Mayo Clin Proc. 2018;93(3):276-277.

Isbrucker RA, Burdock GA. Risk and safety assessment on the consumption of herbal and dietary supplements: Focus on endocrine-active botanicals. Food Chem Toxicol. 2021;152:112198.

Pandit S, Srivastav AK, Sur TK, Chaudhuri S, Wang Y, Biswas TK. Effects of Withania somnifera extract in chronically stressed adults: A randomized controlled trial. Nutrients. 2024;16(9):1293.

Panossian A, Efferth T. Network pharmacology of adaptogens in the assessment of their pleiotropic therapeutic activity. Pharmaceuticals (Basel). 2022;15(9):1051.

Panossian AG, Efferth T, Shikov AN, et al. Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases. Med Res Rev. 2021;41(1):630-703.

Pennisi FM, Bartolone G, Grimaudo S. COVID-19 and adrenal insufficiency: An emerging clinical challenge. Horm Metab Res. 2023;55(2):95-101.

Rabijewski M, Papierska L, Binkowska M, et al. Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women: Position statement of expert panel. Ginekol Pol. 2020;91(9):554-562.

Rogerson O, Wilding S, Prudenzi A, O’Connor DB. Effectiveness of stress management interventions to change cortisol levels: A systematic review and meta-analysis. Psychoneuroendocrinology. 2024;159:106415.

Rushworth RL, Torpy DJ, Falhammar H. Adrenal insufficiency: Diagnosis and management. Med J Aust. 2022;216(7):360-365.

Siwek M, Woroń J, Wrzosek A, Gupało J, Chrobak AA. Adverse events and interactions between adaptogens and antidepressants. Front Pharmacol. 2023;14:1271776.

Speers AB, Cabey KA, Soumyanath A, Wright KM. Effects of Withania somnifera (Ashwagandha) on stress-related neuropsychiatric disorders. Curr Neuropharmacol. 2021;19(9):1468-1495.

Tähkämö L, Partonen T, Pesonen AK. Systematic review of light exposure impact on human circadian rhythm and sleep in the digital age. Sleep Med Rev. 2022;62:101594.

Takahashi H, Matsunaga M. Salivary cortisol modulation following brief mindfulness meditation. Stress Health. 2023;39(3):245-253.

Wiciński M, Fajkiel-Madajczyk A, Kurant Z, et al. Ashwagandha’s multifaceted effects on human health. Nutrients. 2024;16(15):2481.

Zhou G, Wang CZ, Mohammadi S, Sawadogo WR, Ma Q, Yuan CS. Pharmacological effects of ginseng: Multiple constituents and multiple actions on humans. Am J Chin Med. 2023;51(5):1085-1104.

Zhu Y, Qiu L, Jiang F, et al. The effect of dehydroepiandrosterone (DHEA) supplementation on estradiol levels in women: A dose-response meta-analysis of randomized clinical trials. Steroids. 2021;173:108889.

 

CHAPTER 8

Ahluwalia R, Abend S, Boelaert K, et al. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for Endocrinology consensus statement. Clin Endocrinol (Oxf). 2023;99(6):707-726.

American Thyroid Association. ATA Statement on Combination T4/T3 Therapy in Hypothyroidism. Thyroid. 2023;33(7):769-773.

American Thyroid Association. ATA Statement on Desiccated Thyroid Extract. American Thyroid Association website. Updated September 18, 2025. Accessed February 16, 2026.

Bahl S, Taylor PN, Premawardhana LD, et al. Risk of death and adverse effects in patients on liothyronine: a multisource systematic review and meta-analysis. J Clin Endocrinol Metab. 2025;110(11):3278-3288.

Bianco AC. Emerging therapies in hypothyroidism. Annu Rev Med. 2024;75:223-240.

Brito JP, Ross JS, Sangaralingham LR, et al. Association between generic-to-generic levothyroxine switching and thyrotropin levels among US adults. JAMA Intern Med. 2022;182(4):418-425.

Eghtedari B, Correa R. Levothyroxine. In: StatPearls. StatPearls Publishing; 2023.

Gottwald-Hostalek U, Tayrouz Y. A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism. Curr Med Res Opin. 2024;40(12):2035-2046.

Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid. 2014;24(12):1670-1751.

Jonklaas J, Bianco AC, Cappola AR, et al. Evidence-based use of levothyroxine/liothyronine combinations in treating hypothyroidism: a consensus document. Eur Thyroid J. 2021;10(1):10-38.

Joshi SR, Mehta A, Abraham G, et al. Effect of levothyroxine dosing before breakfast versus at bedtime: a systematic review and meta-analysis. Clin Thyroidol. 2020;32(4):159-161.

Liu H, Chen H, Weng J, et al. Medications and food interfering with the bioavailability of levothyroxine: a systematic review. Front Endocrinol (Lausanne). 2023;14:1166481.

Mehran L, Amouzegar A, Foroutan SM, et al. Pharmacodynamic and pharmacokinetic properties of the combined preparation of levothyroxine plus sustained-release liothyronine: a randomized controlled clinical trial. BMC Endocr Disord. 2023;23(1):182.

Meyer LM, Stephens K, Reilly T, et al. Stability and consistency of compounded oral liquid levothyroxine products. J Am Pharm Assoc (2003). 2020;60(6):e46-e53.

Riis KR, Nygaard B, Bonnema SJ. Potential risks and benefits of desiccated thyroid extract for the treatment of hypothyroidism: a review. Thyroid. 2024;34(3):307-318.

Skelin M, Lucijanić T, Liberati-Čizmek AM, et al. Factors affecting gastrointestinal absorption of levothyroxine: a review. Clin Ther. 2017;39(2):378-403.

U.S. Food and Drug Administration. Compounded Drugs and FDA: Questions and Answers. Updated 2023. Accessed February 16, 2026.

U.S. Food and Drug Administration. Levothyroxine Sodium Product Information. Updated March 4, 2022. Accessed February 16, 2026.

U.S. National Library of Medicine. Synthroid (levothyroxine sodium) tablets: Prescribing information (DailyMed). Revised February 2024. Accessed February 16, 2026.

Wiesner A, Gajewska D, Paśko P. Levothyroxine interactions with food and dietary supplements—A systematic review. Nutrients. 2021;13(3):800.

Wilson JB, Rahman A, Shakir MKM. Reverse T3 in patients with hypothyroidism on different thyroid hormone replacement therapies. PLoS One. 2025;20(6):e0325046.

Wiersinga WM. T4 + T3 combination therapy: any progress? Eur Thyroid J. 2019;8(5):238-245.

 

CHAPTER 9

Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome/Willis–Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—history, rationale, description, and significance. Sleep Med. 2014;15(8):860-873.

Baranwal N, Yu PK, Siegel NS. Sleep physiology, pathophysiology, and sleep hygiene. Prog Cardiovasc Dis. 2023;77:59-69.

Baker FC, de Zambotti M, Colrain IM, Bei B. Sleep problems during the menopausal transition: prevalence, impact, and management challenges. Nat Sci Sleep. 2018;10:73-95.

Brewster GS, Riegel B, Gehrman PR. Insomnia in the older adult. Sleep Med Clin. 2022;17(2):233-239.

Cao HJ, Yu ML, Wang LQ, et al. Acupuncture for primary insomnia: an updated systematic review of randomized controlled trials. J Altern Complement Med. 2019;25(5):451-474.

Cardinali DP, Brown GM, Pandi-Perumal SR. Chronotherapy. In: Handb Clin Neurol. 2021;179:357-370.

Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proc Natl Acad Sci U S A. 2015;112(4):1232-1237.

Cheong MJ, Kim S, Kim JS, et al. A systematic literature review and meta-analysis of the clinical effects of aroma inhalation therapy on sleep problems. Medicine (Baltimore). 2021;100(9):e24652.

D’Aurea CVR, Frange C, Poyares D, Souza AAL, Lenza M. Physical exercise as a therapeutic approach for adults with insomnia: systematic review and meta-analysis. Einstein (Sao Paulo). 2022;20:eAO8058.

Erland LAE, Saxena PK. Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. J Clin Sleep Med. 2017;13(2):275-281.

Fatemeh G, Sajjad M, Niloufar R, Neda S, Leila S, Khadijeh M. Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials. J Neurol. 2022;269(1):205-216.

Furukawa Y, Sakata M, Yamamoto R, et al. Components and delivery formats of cognitive behavioral therapy for chronic insomnia in adults: a systematic review and component network meta-analysis. JAMA Psychiatry. 2024;81(4):357-365.

Iftikhar IH, Cistulli PA, Jahrami H, et al. Comparative efficacy of mandibular advancement devices in obstructive sleep apnea: a network meta-analysis. Sleep Breath. 2023;27:1365-1381.

Jaqua EE, Hanna M, Labib W, Moore C, Matossian V. Common sleep disorders affecting older adults. Perm J. 2023;27(1):122-132.

Kyle SD, Siriwardena AN, Espie CA, et al. Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomized controlled trial. Lancet. 2023;402(10406):975-987.

Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep. 2008;31(7):979-990.

Lechat B, Naik G, Reynolds A, et al. Accuracy of at-home sleep testing for the diagnosis of obstructive sleep apnea: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2020;146(6):551-560.

Min Y, Ma Y, Han F, Gao X. Long-term efficacy of mandibular advancement devices in the treatment of adult obstructive sleep apnea: a systematic review and meta-analysis. PLoS One. 2023;18(11):e0292832.

Morin CM, Benca R. Chronic insomnia. Lancet. 2012;379(9821):1129-1141.

Neubauer DN, Pandi-Perumal SR, Spence DW, Buttoo K, Monti JM. Pharmacotherapy of insomnia. J Cent Nerv Syst Dis. 2018;10:1179573518770672.

Passos GS, Youngstedt SD, Santana MG. Exercise as an adjunct treatment to cognitive behavior therapy for insomnia. Sleep Med Clin. 2023;18(1):39-47.

Poza JJ, Pujol M, Ortega-Albás JJ, Romero O; Insomnia Study Group of the Spanish Sleep Society (SES). Melatonin in sleep disorders. Neurologia (Engl Ed). 2022;37(7):575-585.

Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133.

Rana AM, Sankari A. Central sleep apnea. In: StatPearls. Treasure Island, FL: StatPearls Publishing; updated June 11, 2023.

Rosen CL, Auckley D, Benca R, et al. A multisite randomized trial of portable sleep studies and positive airway pressure autotitration versus laboratory-based polysomnography for the diagnosis and treatment of obstructive sleep apnea: The HomePAP study. Sleep. 2012;35(6):757-767.

Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7-S10.

Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349.

Sun SY, Chen GH. Treatment of circadian rhythm sleep-wake disorders. Curr Neuropharmacol. 2022;20(6):1022-1034.

Trauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D. Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(3):191-204.

Wang C, Yang WJ, Yu XT, et al. Acupuncture for insomnia with short sleep duration: protocol for a randomised controlled trial. BMJ Open. 2020;10(3):e033731.

Yeom SW, Chung SK, Lee EJ, et al. Association between septal deviation and obstructive sleep apnea diagnoses: a nationwide 9-year follow-up cohort study. J Clin Sleep Med. 2021;17(10):2099-2106.

​

CHAPTER 10

Adawi M, O’Mahony L, Lindberg G, et al. Effect of a preparation of four probiotics—including Lactobacillus plantarum and Bifidobacterium infantis—on symptoms of patients with IBS and SIBO. BMJ Open Gastroenterol. 2018;5(1):e000230.

Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327(11):749-754.

Asadi A, Shadab Mehr N, Mohamadi MH, et al. Obesity and gut-microbiota-brain axis: A narrative review. J Clin Lab Anal. 2022;36(5):e24420.
Bjarnason I, Scarpignato C, Holmgren E, et al. Mechanisms of damage to the gastrointestinal tract from nonsteroidal anti-inflammatory drugs. Gastroenterology. 2018;154(3):500-514.

Cheng Z, Zhang L, Yang L, Chu H. The critical role of gut microbiota in obesity. Front Endocrinol (Lausanne). 2022;13:1025706.

Efthymakis K, Neri M. The role of Zinc L-Carnosine in the prevention and treatment of gastrointestinal mucosal disease in humans: a review. Clin Res Hepatol Gastroenterol. 2022;46(7):101954.

Eslami M, Yousefi B, Kokhaei P, et al. Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 2019;234(10):17127-17143.

Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117(3):632-639.

Fatima R, Aziz M. Achlorhydria. In: StatPearls. Treasure Island (FL): StatPearls Publishing; August 14, 2023.

Freedberg DE, Toussaint NC, Chen SP, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015;149(4):883-885.e9.

Gibson GR, Hutkins R, Sanders ME, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491-502.

Gomes Maria F, de Souza Izabel W, da Silva Costa C, et al. Lactic acid bacteria: A promising tool for menopausal health. Front Microbiol. 2022;13:9654486.

Greathouse KL, Faucher MA, Hastings-Tolsma M. The Gut Microbiome, Obesity, and Weight Control in Women's Reproductive Health. West J Nurs Res. 2017;39(8):1094-1119.

Holmberg D, Bäckhed F, Gravningen K. Bariatric Surgery in Obesity: Effects on Gut Microbiota and Nutrient Absorption. Nutrients. 2020;12(3):802.

Hrubisko M, Danis R, Huorka M, Wawruch M. Histamine Intolerance—The More We Know the Less We Know. A Review. Nutrients. 2021;13(7):2228.

Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740-748.

Janiak MC. Digestive enzymes of human and nonhuman primates. Evol Anthropol. 2016;25(5):253-266.

Jiang M, Li W, et al. Estrogen deficiency alters gastrointestinal motility and barrier function in postmenopausal women. Am J Physiol Gastrointest Liver Physiol. 2019;317(1):G40–G49.

Jones ML, Martoni CJ, Parent M, Prakash S. Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yogurt formulation in hypercholesterolemic adults. Am J Clin Nutr. 2012;95(6):1145-1154.

Khailova L, Baird CH, Rush AA, Barnes C, Wischmeyer PE. Lactobacillus rhamnosus GG treatment improves intestinal permeability and modulates inflammatory response and homeostasis of spleen and colon in experimental model of Pseudomonas aeruginosa pneumonia. Clin Nutr. 2017;36(6):1549–1557.

Kim MH, Kim H. The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases. Int J Mol Sci. 2017;18(5):1051.

Kocsis AK, Ajandek E, Varga L, et al. Effects of probiotics on lipid profiles in hyperlipidemic individuals: a meta-analysis of randomized controlled trials. PLoS One. 2020;15(3):e0230665.

LeBlanc JG, Chain F, Martín R, et al. Beneficial effects on host energy metabolism of short chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Fact. 2017;16:79.

Liaquat M, Minihane AM, Vauzour D, Pontifex MG. The gut microbiota in menopause: Is there a role for prebiotic and probiotic solutions? Post Reprod Health. Published online May 7, 2025.

Maintz L, Novak N. Histamine and histamine intolerance. Am J Clin Nutr. 2007;85(5):1185-1196.

Maiuolo J, Musolino V, Gliozzi M, et al. Involvement of the Intestinal Microbiota in the Appearance of Multiple Sclerosis: Aloe vera and Citrus bergamia as Potential Candidates for Intestinal Health. Nutrients. 2022;14(13):2711.

Martyniak A, Wójcicka M, Rogatko I, Piskorz T, Tomasik PJ. A Comprehensive Review of the Usefulness of Prebiotics, Probiotics, and Postbiotics in the Diagnosis and Treatment of Small Intestine Bacterial Overgrowth. Microorganisms. 2025;13(1):57.

Magne F, Gotteland M, Gauthier L, et al. The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients? Nutrients. 2020;12(5):1474.

McEwen BS. Central effects of stress hormones in health and disease: understanding the protective and damaging effects of stress and stress mediators. Eur J Pharmacol. 2008;583(2–3):174–185.

Meijer JL, Roderka MN, Chinburg EL, et al. Alterations in Fecal Short-Chain Fatty Acids After Bariatric Surgery: Relationship with Dietary Intake and Weight Loss. Nutrients. 2022;14(20):4243.

Miraghajani M, Mohammadi M, Mirmiran P, Hekmatdoost A. Probiotics and prebiotics: Any role in menopause related diseases? Nutrients. 2021;13(2):613.

Näslund E, Anderlind C, Hellström PM. No cholesterol lowering effect evident of Lactobacillus plantarum 299v in hypercholesterolemic subjects: a randomized, placebo-controlled clinical trial. Lipids Health Dis. 2013;12:112.

Pimentel M, Saad RJ, Long MD, Rao SSC. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Am J Gastroenterol. 2020;115(2):165–178.
Redondo-Cuevas L, Belloch L, Martín-Carbonell V, et al. Do Herbal Supplements and Probiotics Complement Antibiotics and Diet in the Management of SIBO? A Randomized Clinical Trial. Nutrients. 2024;16(7):1083.

Ried K, Travica N, Dorairaj R, Sali A. Herbal formula improves upper and lower gastrointestinal symptoms and gut health in Australian adults with digestive disorders. Nutr Res. 2020;76:37-51.

Roager HM, Christensen LH. Personal diet-microbiota interactions and weight loss. Proc Nutr Soc. 2022;81(3):243-254.

Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroenterol Hepatol. 2019;16(10):605-616.

Shu X, Yu T, Kang K, Zhao J. Effects of glutamine on markers of intestinal inflammatory response and mucosal permeability in abdominal surgery patients: A meta analysis. Exp Ther Med. 2016;12(6):3499-3506.

Sigthorsson G, Tibble J, Hayllar J, et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut. 1998;43(4):506-511.

Steele C. Lactobacillus rhamnosus GG: a review of clinical use and efficacy. Nutr Med J. 2022;1(3):70–116.

Stojanov S, Berlec A, Štrukelj B. The Influence of Probiotics on the Firmicutes/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease. Microorganisms. 2020;8(11):1715.

Thu MS, Ondee T, Nopsopon T, et al. Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis. Biology (Basel). 2023;12(2):280.

Wagner NRF, Fernandes R, Teixeira Frota Reichmann M, Lopes MCP, Welc LLS, Campos ACL. Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis. Obes Surg. 2025;35(1):312-321.

Zafar H, Jimenez B, Schneider A. Small intestinal bacterial overgrowth: current update. Curr Opin Gastroenterol. 2023;39(6):522-528.

 

CHAPTER 11

Achkar JM, Fries BC. Candida infections of the genitourinary tract. Clin Microbiol Rev. 2010;23(2):253-273.

Bassat O, Friedman H, et al. Morphological transitions in Candida albicans and their role in virulence. Virulence. 2015;6(4):331-342.

Brochado MJ, Matos L, Mota M, et al. Diet as a strategy to modulate gut microbiota composition for preventing Candida infections. Front Microbiol. 2023;14:1090795.

Brown GD, Denning DW, Levitz SM. Tackling human fungal infections. Science. 2012;336(6082):647.

Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9(7):327-335.

Cottier F, Pavelka N. Complexity and dynamics of host–fungal interactions. Front Microbiol. 2012;3:173.

Czajka KM, Binder U. Molecular mechanisms associated with antifungal resistance in Candida species. Microorganisms. 2023;11(12):2437.

Fell J, Caraballo R, et al. Antifungal potential of plant-based extracts against Candida species: systematic review of in vitro and in vivo studies. Phytother Res. 2025;In Press.

Gow NAR, Hube B. Importance of the Candida albicans cell wall during commensalism and infection. Curr Opin Microbiol. 2012;15(4):406-412.

Hirota K, Yasuhara Y, et al. Natural compounds with antifungal properties effective against fluconazole-resistant Candida. Antibiotics (Basel). 2023;12(11):1603.

Koh AY. Murine models of Candida gastrointestinal colonization and dissemination. Eukaryot Cell. 2013;12(11):1416-1422.

Lagree K, Mitchell AP. Fungal biofilms: Inside out. Microbiol Spectr. 2017;5(2):10.1128/microbiolspec.funk-0024-2016.

Liu Y, Filler SG. Candida albicans biofilm formation and its clinical consequences. Future Microbiol. 2011;6(12):1463-1473.

Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4(2):119-128.

Miranda LN, van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lemos AS, Levin AS. Candida colonization as a source for candidaemia. J Hosp Infect. 2009;72(1):9-16.

Müller MM, Heldt K, Olek S, et al. Successful management of Candida overgrowth through dietary interventions: A case series. Integr Med (Encinitas). 2016;15(3):34-39.

Netea MG, Joosten LAB, et al. Immune defence against Candida fungal infections. Nat Rev Immunol. 2015;15(10):630-642.

Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1-e50.

Peyton LR, Gallagher S, Hashemzadeh M. Triazole antifungals: a review. Drugs Today (Barc). 2015;51(12):705-718.

Ramage G, Kean R, Rautemaa-Richardson R, Williams C, Lopez-Ribot JL. Fungal biofilms in human health and disease. Nat Rev Microbiol. 2025;23(6):355-370.

Ruan SY, Lee LN, Lin HH, et al. Recurrent candidemia in adult patients with prior candidemia: incidence, risk factors, and outcomes. Clin Microbiol Infect. 2009;15(6):567-572.

Shapiro RS, Robbins N, Cowen LE. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev. 2011;75(2):213-267.

Singh Y. Herbal products and their active constituents used alone and as synergists for conventional antifungals against resistant Candida species. J Fungi (Basel). 2022;8(10):1077.

Swidsinski A, Dorffel Y, Loening-Baucke V, et al. Desquamated epithelial cells covered with a polymicrobial biofilm typical for bacterial vaginosis are present in Candida vaginitis and non-infectious vaginitis. FEMS Immunol Med Microbiol. 2011;61(2):169-177.

Yano J, Sobel JD. Emerging evidence of Candida infections in the genital tract: Pathogenesis and transmission. Curr Infect Dis Rep. 2011;13(6):481-487.